AtriCure, Inc. — Director's Dealing 2019

Jul 3, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AtriCure, Inc. (ATRC)
CIK: 0001323885
Period of Report: 2019-06-30

Reporting Person: Wade M. Andrew (SVP and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-06-30	Common Stock	A	407	$25.36	Acquired	156420	Direct

Footnotes

F1: Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended June 30, 2019.

F2: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on June 28, 2019, which was the last trading day of the applicable offering period. The closing price on June 28, 2019 was $29.84.